DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Scope & Guideline

Transforming Ideas into Effective Therapies

Introduction

Immerse yourself in the scholarly insights of DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0363-9045
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Converge1974, from 1976 to 2024
AbbreviationDRUG DEV IND PHARM / Drug Dev. Ind. Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'Drug Development and Industrial Pharmacy' focuses on advancing the field of pharmaceutical sciences with an emphasis on drug formulation, delivery systems, and industrial practices. It aims to bridge the gap between laboratory research and practical applications in the pharmaceutical industry.
  1. Drug Formulation and Delivery Systems:
    The journal emphasizes innovative drug formulation strategies, particularly those involving nanotechnology, to enhance drug solubility, stability, and bioavailability. This includes the development of nanoemulsions, liposomes, and polymeric nanoparticles for various therapeutic applications.
  2. Quality by Design (QbD) Approaches:
    A core focus is on the application of QbD principles in pharmaceutical development, which ensures that the quality of drug products is built into the formulation process, thereby enhancing product reliability and compliance with regulatory standards.
  3. Pharmacokinetics and Pharmacodynamics:
    Research published in the journal often explores the pharmacokinetic and pharmacodynamic profiles of novel formulations, providing insights into their efficacy and safety in clinical settings.
  4. Natural Products and Phytopharmaceuticals:
    The journal also highlights the use of natural products and phytochemicals in drug development, exploring their potential therapeutic effects and mechanisms of action.
  5. Analytical Methods in Drug Development:
    A significant emphasis is placed on the development and validation of analytical techniques for the characterization of drug formulations, ensuring their quality and performance through rigorous testing.
The journal has seen a rise in interest in several emerging themes, reflecting the latest advancements in drug development and industrial pharmacy practices. These trends highlight the journal's commitment to addressing contemporary challenges in the pharmaceutical field.
  1. Nanotechnology in Drug Delivery:
    There is a significant increase in research focusing on nanotechnology applications in drug delivery systems, including the use of nanocarriers, nanocrystals, and nanoemulsions to improve the pharmacokinetic profiles of drugs.
  2. Personalized Medicine and Targeted Therapies:
    Emerging themes include personalized medicine approaches that cater to individual patient needs, particularly in oncology and chronic diseases, where targeted therapies are becoming more prevalent.
  3. Regenerative Medicine and Drug Delivery Systems:
    The journal is increasingly publishing studies related to regenerative medicine, particularly involving novel drug delivery systems that enhance tissue repair and regeneration.
  4. Sustainable and Green Chemistry:
    There is a growing focus on sustainable practices in drug development, including the use of green chemistry principles to minimize environmental impact and improve the safety of pharmaceutical processes.
  5. Theranostics:
    The integration of therapeutic and diagnostic approaches, or theranostics, is gaining traction, with research exploring how combined therapies can enhance treatment efficacy and patient outcomes.

Declining or Waning

As the field of drug development evolves, certain themes within the journal's scope appear to be declining in prominence. These waning themes reflect shifts in research focus and the increasing prioritization of novel methodologies and technologies.
  1. Traditional Drug Formulation Techniques:
    There is a noticeable decrease in publications focusing on conventional drug formulation methods, such as simple mixing or granulation techniques, as the field shifts towards more sophisticated and technologically advanced approaches.
  2. Single-drug Formulations:
    Research on single-drug formulations is becoming less common, with a growing trend towards combination therapies and multi-drug delivery systems that can enhance treatment efficacy and reduce side effects.
  3. Basic Pharmacological Studies:
    While basic pharmacological studies remain important, there is a decline in the number of publications focusing solely on these aspects without integration into formulation development or delivery systems, as the journal increasingly prioritizes translational research.

Similar Journals

Acta Pharmaceutica Sinica B

Pioneering Innovations in Drug Development
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

Indian Journal of Pharmaceutical Education and Research

Innovating education and research in pharmaceutical sciences.
Publisher: ASSOC PHARMACEUTICAL TEACHERS INDIAISSN: 0019-5464Frequency: 4 issues/year

Indian Journal of Pharmaceutical Education and Research, published by the Association of Pharmaceutical Teachers of India, is a pivotal platform for scholarly discussion in the field of pharmacology, toxicology, and pharmaceutics. ISSN 0019-5464, this esteemed journal aims to foster the exchange of innovative research, clinical advancements, and educational practices within the pharmaceutical sciences community. As a Q3-ranked journal in its category as of 2023, it reflects a commitment to upholding the standards of academic excellence and contributes significantly to the ongoing development of pharmaceutical education. The journal is a valuable resource for researchers, professionals, and students, with content spanning various key areas including drug formulation, safety, and the latest trends in pharmaceutical education. By providing open access to its research and reviews, the journal ensures that vital information is disseminated widely, promoting collaboration and learning among stakeholders in the pharmaceutical sector. Based in Bangalore, India, the journal has been instrumental in highlighting regional research while fostering a global dialogue in pharmaceutical sciences. As it continues its journey from 2008 to 2024, it remains dedicated to impacting the field through rigorous peer-reviewed content and engaging with contemporary challenges in healthcare and education.

DARU-Journal of Pharmaceutical Sciences

Empowering researchers to shape the future of medicine.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

PHARMACIA

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

ACTA POLONIAE PHARMACEUTICA

Exploring the Future of Therapeutics and Pharmacology
Publisher: POLSKIE TOWARZYSTWO FARMACEUTYCZNEISSN: 0001-6837Frequency: 4 issues/year

ACTA POLONIAE PHARMACEUTICA is a well-established peer-reviewed journal published by Polskie Towarzystwo Farmaceutyczne, dedicated to the field of pharmaceutical sciences and pharmacology. With a rich history dating back to 1951, this journal serves as a vital platform for disseminating cutting-edge research and developments in pharmaceutical technology, drug development, and therapeutic therapies. Although it currently operates under a subscription model, its commitment to scientific rigor has earned it a respectable impact factor, placing it in the Q3 and Q4 quartiles respectively for Pharmaceutical Science and Pharmacology as of 2023. Researchers and practitioners alike will find value in its comprehensive coverage of essential topics, as well as its diverse range of contributions from both established and emerging scholars in the field. With its address located in the heart of Warsaw, Poland, ACTA POLONIAE PHARMACEUTICA aims to further bridge the gap between academia and industry, paving the way for innovation in drug discovery and therapeutic applications.

Journal of Reports in Pharmaceutical Sciences

Connecting Scholars and Practitioners in Drug Development.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2322-1232Frequency: 2 issues/year

Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.

Future Journal of Pharmaceutical Sciences

Bridging Research and Practice in the Pharmaceutical Realm
Publisher: SPRINGERISSN: 2314-7245Frequency: 1 issue/year

The Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Driving Excellence in Pharmaceutical Research and Education
Publisher: ELSEVIERISSN: 0928-0987Frequency: 15 issues/year

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

Istanbul Journal of Pharmacy

Transforming ideas into impactful pharmaceutical solutions.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

AAPS Journal

Innovating Solutions for Tomorrow's Pharmacology Challenges.
Publisher: SPRINGERISSN: 1550-7416Frequency: 1 issue/year

AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.